OBJECTIVE: Treatment delays may result in different clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) who receive fibrinolytic therapy vs primary percutaneous coronary intervention (PCI). The aim of this analysis was to examine how treatment delays relate to 6-month mortality in reperfusion-treated patients enrolled in the Global Registry of Acute Coronary Events (GRACE). DESIGN: Prospective, observational cohort study. SETTING: 106 hospitals in 14 countries. PATIENTS: 3959 patients who presented with STEMI within 6 h of symptom onset and received reperfusion with either a fibrin-specific fibrinolytic drug or primary PCI. MAIN OUTCOME MEASURES: 6-month mortality. METHODS: Multivariable logistic regression...
Background : Acute Myocardial Infarction (AMI) is the leading cause of death worldwide and also the ...
International audienceAims: Current guidelines recommend short time delays from qualifying ECG to re...
AIM: To evaluate the relationship between system delay and 30-day and long-term mortality in patient...
Timely reperfusion after ST-elevation myocardial infarction (STEMI) improves survival. Guidelines re...
Aims To examine the extent of delay from initial hospital presentation to fibrinolytic therapy or pr...
Background-—Early reperfusion in the setting of an ST-elevation myocardial infarction (STEMI) is of ...
Background: In several countries, Fibrinolytic therapy represents the main reperfusion therapy for m...
The efficacy of reperfusion therapy is dependent not only by the duration of symptoms before therapy...
Background—Optimal reperfusion strategy in ST-elevation myocardial infarction is controversial. Fail...
Primary angioplasty has been shown to be more effective than fibrinolysis in terms of mortality and ...
Background: The aim of our study was to assess the delay of fibrinolysis in ST elevation myocardial ...
AIMS: The mortality benefit of primary percutaneous coronary angioplasty (PPCI) is time-dependent. ...
ObjectivesWe sought to evaluate the impact of a strategy of reduced-dose fibrinolytic acceleration o...
BACKGROUND: The impact of treatment delays on outcomes after primary percutaneous coronary intervent...
ObjectivesWe sought to determine if an underlying mechanism of the association between prolonged sym...
Background : Acute Myocardial Infarction (AMI) is the leading cause of death worldwide and also the ...
International audienceAims: Current guidelines recommend short time delays from qualifying ECG to re...
AIM: To evaluate the relationship between system delay and 30-day and long-term mortality in patient...
Timely reperfusion after ST-elevation myocardial infarction (STEMI) improves survival. Guidelines re...
Aims To examine the extent of delay from initial hospital presentation to fibrinolytic therapy or pr...
Background-—Early reperfusion in the setting of an ST-elevation myocardial infarction (STEMI) is of ...
Background: In several countries, Fibrinolytic therapy represents the main reperfusion therapy for m...
The efficacy of reperfusion therapy is dependent not only by the duration of symptoms before therapy...
Background—Optimal reperfusion strategy in ST-elevation myocardial infarction is controversial. Fail...
Primary angioplasty has been shown to be more effective than fibrinolysis in terms of mortality and ...
Background: The aim of our study was to assess the delay of fibrinolysis in ST elevation myocardial ...
AIMS: The mortality benefit of primary percutaneous coronary angioplasty (PPCI) is time-dependent. ...
ObjectivesWe sought to evaluate the impact of a strategy of reduced-dose fibrinolytic acceleration o...
BACKGROUND: The impact of treatment delays on outcomes after primary percutaneous coronary intervent...
ObjectivesWe sought to determine if an underlying mechanism of the association between prolonged sym...
Background : Acute Myocardial Infarction (AMI) is the leading cause of death worldwide and also the ...
International audienceAims: Current guidelines recommend short time delays from qualifying ECG to re...
AIM: To evaluate the relationship between system delay and 30-day and long-term mortality in patient...